Japan plans to acquire 145M doses of Moderna, Pfizer/BioNTech COVID vaccines - Reuters
Wachiwit/iStock via Getty Images                 

Japan intends to acquire 145M doses of Moderna (NASDAQ:MRNA), and Pfizer (NYSE:PFE) and BioNTech's (NASDAQ:BNTX) COVID-19 vaccines, Reuters reported citingÂ Kyodo news agency which cited a government source.
Japan has not yet announced any plans for a fourth vaccine dose as the Asian nation is currently undertaking rollout of the third dose (first booster shot).
However, according to local media outlets additional booster rollout could begin in the summer, added the report.